Detalhe da pesquisa
1.
Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
J Immunol
; 212(3): 487-499, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099710
2.
New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Int J Mol Sci
; 23(3)2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163401
3.
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230.
Cancers (Basel)
; 15(9)2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174130
4.
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.
Cancers (Basel)
; 14(1)2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008392